Articles from Pakistan Journal of Nuclear MedicineArticles published in 2026
- Papillary carcinoma arising in Thyroglossal duct cyst – A case report in perspective of 2025 American Thyroid Association Management Guidelines for Adult patients with differentiated thyroid cancer
Hira Tahir Butt, M. Numair Younis, Arzoo Fatima Saleem
Pak J Nucl Med. 2026; 16(1): 52-54
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1780303859
- Radioiodine-refractory thyroid cancer: evolving management under ATA 2025
Wardah Ashfaq, Muhammad Numair Younis
Pak J Nucl Med. 2026; 16(1): 47-51
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1777623387
- Role of FDG PET-CT in differentiated thyroid carcinoma; case series and focus on ATA 2025 guidelines
Hafsa Salahudin, Tanzil Sajid
Pak J Nucl Med. 2026; 16(1): 42-46
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1779085259
- Impact of ATA 2025 guidelines of thyroid cancer management on radiation safety procedures in clinical settings
Hamza Zia, Zainab Tariq, Muhammad Numair Younis, Sadaf Abdul Qadir, Tariq Mahmood Mirza
Pak J Nucl Med. 2026; 16(1): 38-41
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1780312233
- External beam radiotherapy in differentiated thyroid cancer: an updated review of evidence and the 2025 ATA guidelines
Sadia Sadiq, Muhammad Numair Younis, Rab Nawaz Maken, Misbah Masood
Pak J Nucl Med. 2026; 16(1): 33-37
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1780249062
- Radioiodine-induced salivary gland dysfunction: what current guidelines recommend and what we practice in resource-limited settings
Sabeen Zia, Muhammad Iqbal, Shaheen Iqbal, Amir Bahadur, Aakif Ullah Khan
Pak J Nucl Med. 2026; 16(1): 29-32
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1777666065
- From risk to precision: the evolving role of genetics in thyroid cancer management (ATA 2015-2025)
Hamid Shabbir, Muhammad Naeem, Nayyar Rubab, Sumayya Nahid
Pak J Nucl Med. 2026; 16(1): 26-28
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1773893035
- Management of Pediatric Well-Differentiated Thyroid Carcinoma; Evolution of ATA Guidelines from 2015 to 2025
Ayesha Zubair, Muhammad Numair Younis
Pak J Nucl Med. 2026; 16(1): 22-25
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1777718105
- Radioactive iodine therapy in differentiated thyroid cancer: a contemporary scientific commentary based on the 2025 ATA Guidelines
Farkhanda Gillani, Nayyar Rubab, Warda Ahmad, Arzoo Fatima, Shazia Fatima, Muhammad Babar Imran
Pak J Nucl Med. 2026; 16(1): 17-21
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1775907573
- Modern surgical approaches in differentiated thyroid cancer: from ATA 2015 to ATA 2025
Muhammad Naeem, Warda Ahmad, Tania Jabbar, Maria Asghar
Pak J Nucl Med. 2026; 16(1): 14-16
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1775818745
- Thyroid cancer surgery: “less is more” in the light of ATA 2025
Fatima Iqbal, Hafsa Arshad, Ayesha Zubair, Muhammad Hassan Danish
Pak J Nucl Med. 2026; 16(1): 10-13
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1777723029
- Fine-needle aspiration cytology in thyroid nodule evaluation: insights from the ATA 2025 Guidelines
Muhammad Kashif Rahim
Pak J Nucl Med. 2026; 16(1): 06-09
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1777525645
- Improving thyroid cancer care in Pakistan: embracing the ATA 2025 paradigm
Muhammad Numair Younis
Pak J Nucl Med. 2026; 16(1): 04-05
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1785486318
- Thyroid cancer care - ATA perspective 2025: introducing the PJNM special issue
M. Babar Imran, Tania Jabbar
Pak J Nucl Med. 2026; 16(1): 01-03
» Abstract » Full-text PDF » doi: 10.24911/PJNMed.175-1785579097
Pages: 1 |
|
|
